Literature DB >> 4063919

Ketoconazole. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4063919      PMCID： PMC1346366     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  13 in total

1.  Ketoconazole-induced drop in serum and saliva testosterone.

Authors:  T Schürmeyer; E Nieschlag
Journal:  Lancet       Date:  1982-11-13       Impact factor: 79.321

Review 2.  Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections.

Authors:  R C Heel; R N Brogden; A Carmine; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

3.  The influence of gastric acidity on the bio-availability of ketoconazole.

Authors:  J W Van Der Meer; J J Keuning; H W Scheijgrond; J Heykants; J Van Cutsem; J Brugmans
Journal:  J Antimicrob Chemother       Date:  1980-07       Impact factor: 5.790

4.  Pharmacokinetics of ketoconazole in patients with neoplastic diseases.

Authors:  A W Maksymiuk; H B Levine; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

5.  High-dose ketoconazole for treatment of fungal infections of the central nervous system.

Authors:  P C Craven; J R Graybill; J H Jorgensen; W E Dismukes; B E Levine
Journal:  Ann Intern Med       Date:  1983-02       Impact factor: 25.391

6.  Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients.

Authors:  C R Horsburgh; C H Kirkpatrick
Journal:  Am J Med       Date:  1983-01-24       Impact factor: 4.965

7.  Disposition of ketoconazole, an oral antifungal, in humans.

Authors:  C Brass; J N Galgiani; T F Blaschke; R Defelice; R A O'Reilly; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

8.  Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes.

Authors:  D S Loose; P B Kan; M A Hirst; R A Marcus; D Feldman
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

9.  Ketoconazole and candidiasis: a controlled study.

Authors:  W T Hughes; D L Bartley; G G Patterson; H Tufenkeji
Journal:  J Infect Dis       Date:  1983-06       Impact factor: 5.226

10.  Gynecomastia with ketoconazole.

Authors:  R DeFelice; D G Johnson; J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.